tiprankstipranks
Advertisement
Advertisement

RLMD Stock Latest News

Relmada’s NDV-01 Bladder Cancer Trial Moves Into Phase 3: What Investors Should Watch
Company AnnouncementsRelmada’s NDV-01 Bladder Cancer Trial Moves Into Phase 3: What Investors Should Watch
4d ago
RLMD
Relmada Therapeutics Earnings Call Highlights NDV-01 Path
PremiumCompany Announcements
Relmada Therapeutics Earnings Call Highlights NDV-01 Path
25d ago
RLMD
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
PremiumCompany Announcements
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
1M ago
8K
RLMD
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
PremiumThe Fly
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
1M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Relmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
1M ago
RLMD
Relmada Therapeutics appoints Bipin Dalmia as chief business officer
PremiumThe FlyRelmada Therapeutics appoints Bipin Dalmia as chief business officer
1M ago
RLMD
Relmada Therapeutics names Bipin Dalmia chief business officer
Premium
The Fly
Relmada Therapeutics names Bipin Dalmia chief business officer
1M ago
RLMD
Relmada Therapeutics Appoints New Chief Business Officer
Premium
Company Announcements
Relmada Therapeutics Appoints New Chief Business Officer
1M ago
8K
RLMD
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
PremiumThe Fly
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
2M ago
RLMD
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
RLMD
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
PremiumCompany Announcements
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
3M ago
8K
RLMD
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
PremiumCompany Announcements
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
4M ago
RLMD
Relmada Therapeutics files automatic mixed securities shelf
PremiumThe FlyRelmada Therapeutics files automatic mixed securities shelf
4M ago
RLMD
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
Premium
Company Announcements
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
4M ago
8K
RLMD
Relmada Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Relmada Therapeutics initiated with an Overweight at Piper Sandler
6M ago
RLMD
Relmada Therapeutics Charts Aggressive Path After Earnings Call
PremiumCompany Announcements
Relmada Therapeutics Charts Aggressive Path After Earnings Call
6M ago
RLMD
Relmada Highlights NDV-01 Data, Funding in 2025 Results
PremiumCompany Announcements
Relmada Highlights NDV-01 Data, Funding in 2025 Results
6M ago
8K
RLMD
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
PremiumThe Fly
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
6M ago
RLMD
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
PremiumCompany Announcements
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
6M ago
RLMD
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
PremiumCompany AnnouncementsRelmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
6M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
6M ago
RLMD
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
6M ago
GE
MU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >